share_log

Oracle | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lawrence Joseph Ellison(41.8%)

甲骨文 | SC 13G/A:超过5%持股股东披露文件(修正)-Lawrence Joseph Ellison(41.8%)

SEC announcement ·  02/09 16:36
Moomoo AI 已提取核心信息
Oracle Corporation's co-founder, Lawrence Joseph Ellison, has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, disclosing his beneficial ownership of Oracle shares. As of December 31, 2023, Ellison owns 1,152,982,353 shares of Oracle's common stock, which includes options to purchase an additional 7,250,000 shares exercisable within 60 days. This represents 41.8% of the company's class of securities. The filing, dated February 9, 2024, indicates that Ellison has sole voting and dispositive power over the shares, with no shared voting or dispositive power reported. The amendment, identified as No. 33, does not signify any change in Ellison's ownership status of more than five percent of Oracle's securities.
Oracle Corporation's co-founder, Lawrence Joseph Ellison, has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, disclosing his beneficial ownership of Oracle shares. As of December 31, 2023, Ellison owns 1,152,982,353 shares of Oracle's common stock, which includes options to purchase an additional 7,250,000 shares exercisable within 60 days. This represents 41.8% of the company's class of securities. The filing, dated February 9, 2024, indicates that Ellison has sole voting and dispositive power over the shares, with no shared voting or dispositive power reported. The amendment, identified as No. 33, does not signify any change in Ellison's ownership status of more than five percent of Oracle's securities.
甲骨文公司的联合创始人劳伦斯·约瑟夫·埃里森已向美国证券交易委员会提交了经修订的附表13G/A,披露了他对甲骨文股票的实益所有权。截至2023年12月31日,埃里森拥有甲骨文1,152,982,353股普通股,其中包括额外购买可在60天内行使的725万股股票的期权。这占公司证券类别的41.8%。这份日期为2024年2月9日的文件表明,埃里森对股票拥有唯一的投票权和处置权,没有报告共享投票权或处置权。该修正案被确定为第33号,并不表示埃里森对甲骨文超过5%的证券的所有权状况有任何变化。
甲骨文公司的联合创始人劳伦斯·约瑟夫·埃里森已向美国证券交易委员会提交了经修订的附表13G/A,披露了他对甲骨文股票的实益所有权。截至2023年12月31日,埃里森拥有甲骨文1,152,982,353股普通股,其中包括额外购买可在60天内行使的725万股股票的期权。这占公司证券类别的41.8%。这份日期为2024年2月9日的文件表明,埃里森对股票拥有唯一的投票权和处置权,没有报告共享投票权或处置权。该修正案被确定为第33号,并不表示埃里森对甲骨文超过5%的证券的所有权状况有任何变化。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息